BAY-3630942

N/A

Report date: 2025/09/19 17:44:51

Base Information

Drug NameBAY-3630942

Drug Alias NameBAY3630942BAY-3630942

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyRadiation-emitting products > Nuclides > Zirconium > 89ZrRadiation-emitting products > Radioactive diagnostic agent +[4]

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsSolid tumoursCarcinoma, Hepatocellular

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesBayer AG

China Registration ClassN/A

Develop Information

Active CompaniesBayer AG

Inactive CompaniesN/A

Active IndicationsSolid tumoursCarcinoma, Hepatocellular

Inactive IndicationsN/A

Other Information

ATC CodeN/A